First Edition: Thursday, Sept. 26, 2024
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
4,261 - 4,280 of 112,886 Results
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
KFF Health News’ Midwest correspondent Cara Anthony sat down with WORLD executive producer Chris Hastings to discuss the origins of our “Silence in Sikeston” project, a multimedia collaboration from KFF Health News, Retro Report, and WORLD that explores the impact of a 1942 lynching and a 2020 police shooting on a rural Missouri community.
Coldwater Creek in suburban St. Louis has exposed generations of children to radioactive material left after World War II, the Missouri Independent reports. Meanwhile, the EPA's data on the Ohio train derailment is said to obfuscate contamination levels.
New cellphone systems mean callers to the 988 suicide and crisis line will have their calls routed to help centers based on their location. Among other news, the former clinical director of Maryland’s main state-run mental hospital had his medical license suspended for a harassment issue.
The genetic disorder, which is fatal, affects the nervous system and other organs — IntraBio's drug Aqneursa was shown to help reduce symptoms compared to a placebo. Separately, Amgen reported success for eczema and myasthenia gravis treatments.
Adam Meyers, a senior vice president, testified to a House panel about what caused the global outage in July that affected major industries, including health care.
The Hill reports on the updated recommendations, including that travelers who “anticipate certain sexual exposures” while in countries where clade I mpox is endemic should be fully vaccinated. Also in the news: Biden promises mpox aid, California continues free covid vaccine program, researchers examine covid's long-term impacts on the brain, and more.
The Vermont independent says he has secured pledges from the major PBMs that they would not limit coverage of Ozempic and Wegovy if the company lowers its list prices — an announcement that CEO Lars Fruergaard Jorgensen says he wasn't aware of heading into the congressional hearing.
In granting a preliminary injunction, the judge signaled the rule is a violation of freedom of religion. Meanwhile, Senate Republicans blocked a resolution that would have guaranteed access to abortion care in emergency situations.
Today's early morning highlights from the major news organizations.
The number of new diagnoses in 2023 was 133, the lowest it has been in decades. The abrupt drop in infections represents a success after years of slow progress against the disease. Also in the news: A study shows diabetes drug metformin might slow aging.
Lawyers for the gunman, who fatally shot 10 people in a Boulder grocery store in 2021, tried to argue his mental illness made him incapable of knowing right from wrong. Jurors disagreed. Other news includes a battle over a DuPont trust, the drug-related death of a trans activist, and more.
Colorado's law, passed last year, to make Amneal provide free generic EpiPens to pharmacies is facing a challenge from the company, which argues it's effectively an illegal property taking. Among other news, Purdue Pharma's settlement talks with the Sackler family are extended to November.
In addition to seeking damages in its lawsuit, Particle Health wants Epic to discontinue its alleged anticompetitive practices in regards to patient data.
New York Gov. Kathy Hochul, a Democrat, on Monday announced ways the state will try to curb the disease's spread, including making mosquito repellent available to visitors at state parks and campgrounds.
As more patients switched to remote patient monitoring, the cost to Medicare ballooned to $311 million, up from just $15 million in 2019 before the covid-19 pandemic. Also in the news: telehealth addiction treatment, the organ transplant network, and more.
The unanimous consent effort is intended to show just where lawmakers stand on this issue ahead of November's general election. It is not expected to pass.
Editorial writers tackle these public health issues.
About 1 in 10 of survey respondents indicated they are severely obese. It's too soon to know whether obesity treatments and drugs will ease the problem, researchers say. Meanwhile, Novo Nordisk's CEO is expected to testify today in a Senate panel hearing about the high cost of weight loss drugs.
© 2026 KFF